Search

everythinglearnresearchcommunity

for

Search:↓

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

People with alopecia areata may have a higher risk of blood clots.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

New treatments for PCOS focus on managing symptoms and improving fertility.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Women with PCOS have altered brain structure and reduced cognitive performance.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.